- 1、本文档共5页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
2003 西班牙 阿威链霉菌转化啤酒糟为羟基苯乙烯酸
Enzyme and Microbial Technology 32 (2003) 140–144
Growth and release of hydroxycinnamic acids from Brewer’s
spent grain by Streptomyces avermitilis CECT 3339
Begoña Bartolomé a , Carmen Gómez-Cordovés a a ´ b
, Ana I. Sancho , Nardy Dıez ,
Patricia Ferreira b , Juan Soliverib , José L. Copa-Patiñob,∗
a Department of Sectorial Technologies, Instituto de Fermentaciones Industriales, CSIC, Juan de la Cierva 3, 28006 Madrid, Spain
b Department of Microbiology and Parasitology, University of Alcalá, Alcalá de Henares, 28871 Madrid, Spain
Received 3 January 2002; received in revised form 3 October 2002; accepted 5 October 2002
Abstract
Streptomyces avermitilis CECT 3339 is grown on Brewer’s spent grain (BSG) and the production of feruloyl esterase (FAE) and
(1 → 4)--d-xylan xilanohydrolase (xylanase) activities is studied over 5 days. Maximum level of xylanases was found at day 1. FAE
activity on methyl ferulate reached a maximum level at day 2, whereas FAE activity on feruloylated oligosaccharides, either from wheat
bran or sugar-beet pulp, was maximal at day 1. The cultures (1–5 days) from S. avermilitis CECT 3339 grown on BSG and on other two
agro-industrial residues such as de-starched wheat bran and sugar-beet pulp were tested for the release of hydroxycinnamic acids (ferulic
and p -coumaric acids) from BSG. Most ferulic acid (FA) was released when culture supernatants from day 1 and BSG as carbon source
(43% of total alkali-extractable ferulic acid) and from day 2 and de-starched wheat bran as carbon source (41.2%) were used. The level of
p -coumaric
您可能关注的文档
- 广东省人民医院2012年住院患者_省略_氨溴索注射剂超说明书用药情况调查_周婧.pdf
- 单病种质量监测指标解读.pdf
- 药理学名解集.doc
- 药物不良反应(ADR)系列问答.doc
- Hip Hip ARRAY…Expanding and Modifying Records With an ARRAY.pdf
- 浅论中国医药企业价格战原因及对策.doc
- 复方吲达帕胺方案20100913.pdf
- 转化医学的概念、研究热点及其前景.pdf
- 抗表皮生长因子受体和抗血管内皮生长因子药物在非小细胞肺癌治疗中的作用.pdf
- 国际药品不良反应信息资源介绍_夏芸.pdf
- 分析let s单元56ago2卷纸zheng unit56.pdf
- 塑胶材料其它分类原料pa9t 12.pdf
- md16x16数字媒体切换器设备.pdf
- 者参考项目发起人学科类型单位序列承包商修订页代码顺序典型.pdf
- 届世界天然气大会阿姆斯特丹2006add10288.pdf
- 期测试记录表每周weekly g1g6 journeys tests level 6 lesson26.pdf
- modernize-whitepaper现代化您应用程序白皮书.pdf
- anybackup产品典型案例分析.pdf
- 约克金融工程课程tfeslide32.pdf
- 广州市妇女儿童医疗中心历份教学药历01tjy.pdf
文档评论(0)